Cryoport Inc (CYRX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Cryoport inc   (NASDAQ: CYRX)
 

Cryoport Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cryoport Inc inventory turnover ratio, the Cryoport Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 4.4 in the second quarter 2026, yet the ratio remained below the average, as CYRX's market remain challenging.Average inventory processing period, for the Cryoport Inc in Jun 30 2026 quarter, has decreased to 83 days, compare to 86 days, in the Mar 31 2026 quarter.

Within Healthcare sector 87 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 648, from total ranking in the first quarter 2026 at 705.

CYRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cryoport Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYRX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -6.64 % -6.81 % 3.2 % -0.96 % -2.43 %
Y / Y Cost of Sales Growth 8.6 % 15.56 % -26.39 % -26.76 % -25.7 %
Inventory Turnover Ratio (TTM) 4.4 4.23 4.01 4.41 4.76
CYRX's Total Ranking # 648 # 705 # 510 # 691 #
Average inventory processing period 83 86 91 83 77
Seq. Inventory Growth -1.12 % -6.2 % -0.59 % 1.26 % -1.31 %
Seq. Cost of Sales Growth 1.01 % 9.04 % 3.63 % -4.86 % 7.49 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 18
Healthcare Sector # 88
Overall Market # 648

Inventory Turnover Ratio Statistics
High Average Low
69.96 34 4.01
(Sep 30 2018)   (Dec 31 2025)



CYRX Company Profile >> Back to CYRX Efficiency Comparisons >> Compare CYRX Inventory Turnover Ratio to its Competitors

Financial Statements
Cryoport Inc 's Inventories $ 22 Millions Visit CYRX's Balance sheet
Cryoport Inc 's Cost of Revenues TTM $ 99 Millions Visit CYRX's Income Statement
What are CYRX's Sales? Visit CYRX's Sales by Segment

Other Inventory Turnover Ratios
Cryoport Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CYRX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CYRX's Competitors
Inventory Turnover Ratio for CYRX's Suppliers
Inventory Turnover Ratio for CYRX's Customers

You may also want to know
CYRX's Sales Growth Rates CYRX's Pe Price to earnings ratio CYRX's Receivables Turnover Ratio CYRX's Stock Quote
CYRX's Net Income Growth Rates CYRX's Ps Price to Sales ratio CYRX's Sales per Employee CYRX's Asset Turnover Ratio
CYRX's Net Margin CYRX's Pb Price to Book ratio CYRX's Financial Strength Ratios CYRX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions

Date modified: 2026-09-07T22:12:30+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.